Skip to the page

Data / Form D filings / Spogen Biotech Inc.

Spogen Biotech Inc.: Form D filings

Spogen Biotech Inc., a technology company in Columbia, MO, filed 2 Form D notices with the SEC between 2011 and 2012. The latest, on September 4, 2012, reports an offering of $850,000 with nothing sold yet.

Find out what Spogen Biotech Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1601 SOUTH PROVIDENCE RD., SUITE 120, Columbia, MO, 65211
Phone
(573) 884-7442
Industry
Other Technology
Entity type
Corporation
Incorporated in
Missouri
Year incorporated
2011
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 505
SEC identifier (CIK)
1529296

The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Other Technology: 8,166 rows, $161.66, or the new rows each week for $19.25 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 4, 2012New notice$850,000$0$850,0000Yet to occursec.gov
Sep 9, 2011New notice$500,000$55,000$445,0003Aug 28, 2011sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Steven Lynn Capkovic TrampeDirector
Katie Lynn Capkovic ThompsonExecutive Officer, Director
Brian Matthew ThompsonExecutive Officer, Director

Other technology companies in Missouri that filed recently

Every Form D from the week of Sep 3, 2012 · All recent filings in Missouri · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Spogen Biotech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.